XML 53 R23.htm IDEA: XBRL DOCUMENT v3.19.1
Note 17 - Stock Based Compensation
12 Months Ended
Dec. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
NOTE
17
– STOCK BASED COMPENSATION
 
Adoption of Equity Compensation Plan
 
On
November 29, 2017,
the Board adopted the
2017
Equity Compensation Plan (the “Plan”) providing for the granting of options to purchase shares of common stock, restricted stock awards and other stock-based awards to directors, officers, employees, advisors and consultants. The Company reserved
20,000,000
shares of common stock for issuance under the Plan. The Plan is intended to provide equity incentives to persons retained by our Company.
 
Equity Compensation Grants
 
On
November 30, 2017,
the Company granted a
one
-time equity award (“Equity Award”) of
20,000
restricted shares of the Company’s common stock pursuant to a Restricted Stock Agreement, to each of the following executives and directors of the Company: Bahige “Bill” Chaaban, Chairman of the Board and President of the Company; Joseph Byrne, Chief Executive Officer and Director; Richard Boswell, Senior Executive Vice President, Chief Financial Officer and Director; Brian Payne, Vice President and Director; Donald Strilchuck, Director; Harold Aubrey de Lavenu, Director; Alex Tarrabain, Director; and Ameen Ferris, Director. The Equity Awards vested immediately.
 
In addition, as part of this
one
-time equity award, Donald Strilchuck, Director, received an additional
1,000,000
restricted shares of the Company's common stock for security consulting services, of which
550,000
vested immediately and the remaining vesting ratably each month over the next
36
months. Other individuals received a total of
1,870,000
restricted shares of the Company's common stock for consulting services performed, of which
1,330,000
vested immediately and the remaining vesting ratably each month over the next
36
months. The expense related to the restricted stock awarded to non-employees for services rendered was recognized on the grant date.
 
On
June 7, 2018,
the Company elected Dr. Usamakh Saadikh to serve as a director of the Company. As compensation for his role as a Director, the company granted a
one
-time equity award of
20,000
shares of the Company’s common stock. This award vested immediately.
 
On
June 19, 2018,
the Company entered into an agreement with a law firm for the payment of its services under which the Company issued
125,000
shares of its common stock. This award vested immediately. The expense related to the restricted stock awarded to non-employees for services rendered was recognized on the grant date.
 
On
December 31, 2018,
the Company issued
12,120
shares of its common stock to individuals for the payment of their services. These awards vested immediately. The expense related to the stock awarded to non-employees for services rendered was recognized on the grant date.
 
Employment Agreements
 
On
November 30, 2017,
employment agreements were entered into with
four
key members of management:
 
Under the Employment Agreement with Bahige (Bill) Chaaban, President of the Company, Mr. Chaaban will receive compensation in the form of a base annual salary of
$31,200
and a grant of
8,750,000
shares of restricted stock of the Company, of which
7,400,000
vested immediately and the remaining vesting ratably each month over the next
36
months.
   
Under the Employment Agreement with Joseph Byrne, Chief Executive Officer of the Company, Mr. Byrne will receive compensation in the form of a base annual salary of
$31,200
and a grant of
1,250,000
shares of restricted stock of the Company, of which
325,000
vested immediately and the remaining vesting ratably each month over the next
36
months.
 
Under the Employment Agreement with Richard Boswell, Senior Executive Vice President and Chief Financial Officer of the Company, Mr. Boswell will receive compensation in the form of a base annual salary of
$31,200
and a grant of
4,500,000
shares of restricted stock of the Company, of which
4,140,000
vested immediately and the remaining vesting ratably each month over the next
36
months.
 
Under the Employment Agreement with Brian Payne, Vice President of the Company, Mr. Payne will receive compensation in the form of a base annual salary of
$31,200
and a grant of
750,000
shares of restricted stock of the Company, of which
300,000
vested immediately and the remaining vesting ratably each month over the next
36
months.
 
Restricted Stock Awards
 
The grant-date fair value of the restricted shares noted in the employment agreements and equity compensation grants sections above was
$102,141
and
$11,333,600
for grants in
2018
and
2017,
respectively. The grant-date fair value is calculated utilizing an enterprise valuation model as of the date the awards are granted. During
2017,
14,317,500
of these shares vested, with the remaining restricted stock units of
3,962,500
shares vesting pro-rata over the requisite service period, which is generally
three
years from the grant-date. In addition to the
157,120
shares that were granted and immediately vested during
2018,
an additional
1,350,000
shares vested. Non-vested restricted stock awards participate in dividends and recipients are entitled to vote these restricted shares during the vesting period.
 
Compensation expense, broken out by allocation, recognized in connection with the restricted stock awards was as follows for the years ended
December 31:
 
   
2018
   
2017
 
                 
Stock Based Compensation
  $
682,000
    $
7,777,900
 
Professional fees
   
12,241
     
806,000
 
Security consulting - related party
   
-
     
620,000
 
Legal
   
77,500
     
161,200
 
                 
Total
  $
771,741
    $
9,365,100
 
 
Non-vested restricted stock award activity for the years ended
December 31, 2018
and
2017
are as follows:
 
   
Number of
Shares
   
Weighted-
Average Grant
Date Fair Value
per Share
   
Weighted-
Average
Remaining
Contractual
Term
(Years)
 
Non-vested at January 1, 2017
   
-
    $
-
     
-
 
Granted
   
18,280,000
     
0.62
     
3.00
 
Vested
   
(14,317,500
)    
0.62
     
-
 
Forfeited
   
-
     
-
     
-
 
Non-vested at December 31, 2017
   
3,962,500
     
0.62
     
2.92
 
Granted
   
157,120
     
0.65
     
-
 
Vested
   
(1,507,120
)    
0.62
     
-
 
Forfeited
   
-
     
-
     
-
 
Non-vested at December 31, 2018
   
2,612,500
    $
0.62
     
2.00
 
 
The fair value of the restricted stock grants was based on the valuation of a
third
-party specialist. Unrecognized compensation expense related to restricted stock amounted to approximately
$1,298,900
as of
December 31, 2018.
This expense will be recognized over vesting period of the respective awards.